Molecular Structure & Design, Bristol Myers Squibb Research & Development, PO Box 4000, Princeton, NJ 08543-4000, USA.
Protein Science, Bristol Myers Squibb Research & Development, PO Box 4000, Princeton, NJ 08543-4000, USA.
Acta Crystallogr F Struct Biol Commun. 2024 Nov 1;80(Pt 11):302-313. doi: 10.1107/S2053230X24009233. Epub 2024 Oct 14.
Heat-shock protein 47 (HSP47) is a potential target for inhibitors that ameliorate fibrosis by reducing collagen assembly. In an effort to develop a structure-based drug-design system, it was not possible to replicate a previous literature result (PDB entry 4au4) for apo dog HSP47; instead, crystal forms were obtained in which pairs of dog HSP47 molecules interacted through a noncleavable C-terminal His-tag to build up tetramers, all of which had multiple molecules of HSP47 in the asymmetric unit and none of which diffracted as well as the literature precedent. To overcome these difficulties, a two-pronged approach was followed: (i) the His-tag was moved from the C-terminus to the N-terminus and was made cleavable, and (ii) Adnectin (derived from the tenth domain of human fibronectin type III) crystallization chaperones were developed. Both approaches provided well diffracting crystals, but the latter approach yielded crystal forms with only one or two HSP47 complexes per asymmetric unit, which made model building less onerous.
热休克蛋白 47(HSP47)是一种潜在的抑制剂靶点,通过减少胶原蛋白组装来改善纤维化。为了开发基于结构的药物设计系统,无法复制以前文献中关于apo 狗 HSP47 的结果(PDB 条目 4au4);相反,获得了晶体形式,其中狗 HSP47 分子通过不可切割的 C 末端 His 标签相互作用形成四聚体,所有这些四聚体在不对称单元中都有多个 HSP47 分子,而且没有一个衍射效果像文献先例那样好。为了克服这些困难,采用了双管齐下的方法:(i)将 His 标签从 C 末端移动到 N 末端,并使其可切割,(ii)开发了 Adnectin(源自人纤维连接蛋白 III 第十个结构域)结晶伴侣。这两种方法都提供了良好衍射的晶体,但后一种方法仅在不对称单元中产生一个或两个 HSP47 复合物的晶体形式,这使得模型构建不那么繁重。